• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.89% Nasdaq Up1.84%

    Repros Therapeutics Inc. (RPRX)

    -NasdaqCM
    8.94 Up 0.41(4.81%) 3:21PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development6,107  7,450  7,325  5,780  
    Selling General and Administrative1,277  1,256  1,226  1,365  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (7,384) (8,706) (8,551) (7,145)
    Income from Continuing Operations
    Total Other Income/Expenses Net2  3  2  3  
    Earnings Before Interest And Taxes(7,382)(8,703)(8,549)(7,142)
    Interest Expense -   -   -   -  
    Income Before Tax(7,382)(8,703)(8,549)(7,142)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(7,382)(8,703)(8,549)(7,142)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,382) (8,703) (8,549) (7,142)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,382) (8,703) (8,549) (7,142)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.